31 Mar 2014

Participants sought for new research studies in gluten, diabetes, depression, schizophrenia

Participants sought: An adjunctive pro-cognitive treatment in schizophrenia
This study by Monash Alfred Psychiatry Research Centre (MAPrc) is being conducted in order to determine if two different doses of EVP-6124 improve mental function and are safe in people who have schizophrenia and are taking another medication for their illness. Contact: Mr Daniel Grice ph (03) 9076 6581 Email participate.maprc@monash.edu Website link: http://www.maprc.org.au/psychopharmacology.